Continuous monitoring in diabetes care enhances access, convenience, adherence, and glycemic control. Challenges in digital-only solutions include trust-building and limitations in face-to-face interactions, along with the lack of engagement by care teams outside the clinic setting. A hybrid model where providers incorporate both remote data monitoring and engagement with in-person visits would address these challenges. The aim of this study is to evaluate the impact of implementing the hybrid care approach on patients with T2D on glycemic control and clinical outcomes. A retrospective case-control observational study over 3 months by a hybrid provider (GluCare.Health) in the UAE included patients with T2D (n=262). The case group had both in-clinic visits and bi-weekly virtual engagements via an app that included a range of caregivers (physicians, dietitians, educators and coaches, n=162). The control group only conducted in-clinic visits without virtual engagement mimicking traditional, episodic care (n=100). Engagement data included dietary, lifestyle, medication, exercise and continuous glucose monitoring interactions. The case group (hybrid model) showed significant HbA1c improvements (-2.19%) (-25%) compared to the control group (-0.10%). Patients with higher baseline HbA1c (≥ 9.0%) experienced greater reductions (-3.67%) (-34%). The case group also showed improvements in weight (-6%), BMI (-6%), LDL (-21%), total cholesterol (-17%), and CVD risk (-41%). The control group had smaller improvements (p >0.05). Engagement strongly correlated with better outcomes; patients with ≥11 interactions (over 90 days) showed significant reductions in HbA1c (-2.38%) and weight (-6.00 kg) in comparison with those <11. The GluCare.Health hybrid model demonstrates promising outcomes in Type 2 diabetes management with a strong correlation between the number of remote engagement and outcomes in comparison to results seen in the physical-only (traditional-care like) control group. Disclosure I. Almarzooqi: None. H. Zakaria: None. M. Caccelli: None. C. Ozkan: None. J. Bangayan: None. M.C. Dandan: None. D. Divino: None. S. Aleabova: None. Y. Said: None. A. Hashemi: None.

中文翻译：

---

1092-P：2 型糖尿病混合护理模式的有效性 — 为期三个月的评估


糖尿病护理中的持续监测增强了可及性、便利性、依从性和血糖控制。纯数字解决方案面临的挑战包括建立信任和面对面互动的限制，以及诊所之外的护理团队缺乏参与。提供商将远程数据监控和亲自访问相结合的混合模式将解决这些挑战。本研究的目的是评估对 T2D 患者实施混合护理方法对血糖控制和临床结果的影响。阿联酋一家混合医疗服务提供商 (GluCare.Health) 进行了一项为期 3 个月的回顾性病例对照观察研究，纳入了 2 型糖尿病患者 (n=262)。病例组通过一个应用程序进行门诊就诊和每两周一次的虚拟参与，其中包括一系列护理人员（医生、营养师、教育工作者和教练，n = 162）。对照组仅进行门诊就诊，没有模仿传统的间歇性护理的虚拟参与（n = 100）。参与数据包括饮食、生活方式、药物、运动和持续血糖监测相互作用。与对照组（-0.10%）相比，病例组（混合模型）的 HbA1c 显着改善（-2.19%）（-25%）。基线 HbA1c 较高 (≥ 9.0%) 的患者下降幅度更大 (-3.67%) (-34%)。病例组的体重 (-6%)、BMI (-6%)、LDL (-21%)、总胆固醇 (-17%) 和 CVD 风险 (-41%) 也有所改善。对照组的改善较小（p > 0.05）。参与度与更好的结果密切相关；与<11次相互作用的患者相比，相互作用次数≥11次（超过90天）的患者的HbA1c（-2.38%）和体重（-6.00 kg）显着降低。葡萄糖护理。健康混合模型展示了 2 型糖尿病管理的有希望的结果，与纯物理（类似传统护理）对照组的结果相比，远程参与的数量和结果之间存在很强的相关性。披露 I. Almarzooqi：无。 H.扎卡里亚：没有。 M·卡切利：没有。 C. 奥兹坎：没有。 J. Bangayan：没有。 MC丹丹：没有。 D. Divino：没有。 S. Aleabova：没有。 Y. 说：没有。 A·哈希米：没有。